dc.contributor.author |
Hawli Y.M.A. |
dc.contributor.author |
Zantout M.S. |
dc.contributor.author |
Azar S.T. |
dc.contributor.editor |
|
dc.date |
2009 |
dc.date.accessioned |
2017-10-05T15:39:20Z |
dc.date.available |
2017-10-05T15:39:20Z |
dc.date.issued |
2009 |
dc.identifier |
10.1016/j.curtheres.2009.02.001 |
dc.identifier.isbn |
|
dc.identifier.issn |
|
dc.identifier.uri |
http://hdl.handle.net/10938/16809 |
dc.description.abstract |
Background: Ramadan, the ninth month of the Islamic lunar calendar, is the holy month of fasting for adolescent and adult Muslims. Observance of Ramadan is considered obligatory for every healthy adult Muslim. During this time, Muslims refrain from eating, drinking, smoking, and administering oral or parenteral medications from sunrise to sunset daily for 28 to 30 days. Case summary: We evaluated the need for changes in basal insulin regimen in 5 patients (4 males and 1 female; age range, 15-19 years) with type 1 diabetes mellitus (T1DM) who fasted during Ramadan. The patients were receiving insulin pump therapy with regular human insulin and maintained weekly visits with their endocrinologist at The Chronic Care Center (Beirut, Lebanon). They were instructed to break the fast after any episode of hypoglycemia (finger stick glucose 70 mg-dL) or severe hyperglycemia (finger stick glucose ≥300 mg-dL or any hyperglycemia associated with presence of urine ketone bodies on urinary dipstick). Blood glucose concentrations did not change significantly with fasting. Finger stick blood glucose taken at 4-hour intervals decreased in the afternoon (at 4 pm) and increased in the evening and morning (10 pm and 8 am, respectively) during this month in 4 of 5 patients, while no significant change in circadian rhythm of finger stick blood glucose was observed in 1 patient. Based on the investigators' findings, the basal insulin requirement decreased by 5.5percent to 25.0percent (4 patients) or did not change (1 patient) during the fast. Changes in regimens, based on collaboration between the endocrinologist and diabetes educational nurse, were determined by blood glucose self-monitoring done at 4-hour intervals during the fasting period, pre-Suhur (predawn breakfast), and ≥2 hours after Iftar (evening fast-breaking meal). No cases of keto-acidosis or severe hypoglycemia were reported. Conclusion: These 5 adolescent and adult patients with T1DM who were using an insulin pump were able to fast during Ramadan without incidences of severe hypoglycemia or ketoacidosis by using close blood glucose self-monitoring and weekly follow-up with their endocrine team, which consisted of an endocrinologist, a registered nutritionist, and a diabetes educational nurse. © 2009 Excerpta Medica Inc. All rights reserved. |
dc.format.extent |
|
dc.format.extent |
Pages: (29-34) |
dc.language |
English |
dc.publisher |
BRIDGEWATER |
dc.relation.ispartof |
Publication Name: Current Therapeutic Research - Clinical and Experimental; Publication Year: 2009; Volume: 70; no. 1; Pages: (29-34); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Adjusting the basal insulin regimen of patients with type 1 diabetes mellitus receiving insulin pump therapy during the Ramadan fast: A case series in adolescents and adults |
dc.type |
Article |
dc.contributor.affiliation |
Hawli, Y.M.A., Department of Internal Medicine, Division of Endocrinology, American University, New York, NY, United States, The Chronic Care Center, Beirut, Lebanon |
dc.contributor.affiliation |
Zantout, M.S., Department of Internal Medicine, Division of Endocrinology, American University, New York, NY, United States |
dc.contributor.affiliation |
Azar, S.T., Department of Internal Medicine, Division of Endocrinology, American University, New York, NY, United States, The Chronic Care Center, Beirut, Lebanon |
dc.contributor.authorAddress |
Azar, S.T.; Department of Internal Medicine, Division of Endocrinology, American University, New York, NY, United States; email: sazar@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Endocrinology; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
Endocrinology |
dc.contributor.authorEmail |
sazar@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Hawli, YMA |
dc.contributor.authorInitials |
Zantout, MS |
dc.contributor.authorInitials |
Azar, ST |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Azar, ST (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Endocrinol, 3 Dag Hammarskjod Plaza,8th Floor, New York, NY 10017 USA. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Al-Arouj M, 2005, DIABETES CARE, V28, P2305, DOI 10.2337-diacare.28.9.2305; Azar Sami T, 2008, J Med Liban, V56, P46; Azizi F, 1998, INT J RAMADAN FASTIN, V2, P8; Benaji B, 2006, DIABETES RES CLIN PR, V73, P117, DOI 10.1016-j.diabres.2005.10.028; Friedrich I., 2000, Harefuah, V138, P19; Kadiri A, 2001, DIABETES METAB, V27, P482; Kassem HS, 2005, J ENDOCRINOL INVEST, V28, P802; Pinar Rukiye, 2002, Br J Nurs, V11, P1300; RASHED AH, 1992, BRIT MED J, V304, P521; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337-diacare.27.10.2306 |
dc.description.citedCount |
1 |
dc.description.citedTotWOSCount |
2 |
dc.description.citedWOSCount |
2 |
dc.format.extentCount |
6 |
dc.identifier.articleNo |
|
dc.identifier.coden |
CTCEA |
dc.identifier.pubmedID |
|
dc.identifier.scopusID |
62849105118 |
dc.identifier.url |
|
dc.publisher.address |
685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Curr. Ther. Res.-Clin. Exp. |
dc.relation.ispartOfIssue |
1 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Current Therapeutic Research - Clinical and Experimental |
dc.relation.ispartofPubTitleAbbr |
Curr. Ther. Res. Clin. Exp. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
70 |
dc.source.ID |
WOS:000264511600004 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
blood glucose concentration |
dc.subject.otherAuthKeyword |
diabetes control |
dc.subject.otherAuthKeyword |
insulin pump therapy |
dc.subject.otherAuthKeyword |
Ramadan fasting |
dc.subject.otherAuthKeyword |
type 1 diabetes |
dc.subject.otherChemCAS |
human insulin, 11061-68-0 |
dc.subject.otherIndex |
human insulin |
dc.subject.otherIndex |
ketone body |
dc.subject.otherIndex |
adolescent |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
circadian rhythm |
dc.subject.otherIndex |
clinical article |
dc.subject.otherIndex |
diabetes control |
dc.subject.otherIndex |
diet restriction |
dc.subject.otherIndex |
drinking |
dc.subject.otherIndex |
eating |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
follow up |
dc.subject.otherIndex |
glucose blood level |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
hyperglycemia |
dc.subject.otherIndex |
hypoglycemia |
dc.subject.otherIndex |
insulin dependent diabetes mellitus |
dc.subject.otherIndex |
insulin pump |
dc.subject.otherIndex |
ketoacidosis |
dc.subject.otherIndex |
ketonuria |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
meal |
dc.subject.otherIndex |
moslem |
dc.subject.otherIndex |
outcome assessment |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
religion |
dc.subject.otherIndex |
self monitoring |
dc.subject.otherKeywordPlus |
|
dc.subject.otherWOS |
Medicine, Research and Experimental |
dc.subject.otherWOS |
Pharmacology and Pharmacy |